Chandrasekaran Ananth, Toh Kai Yee, Low Sean Haoquan, Tay Stacey Kiat Hong, Brenner Sydney, Goh Denise Li Meng
Singapore Institute of Clinical Sciences, Singapore.
Cell Signal. 2008 Jan;20(1):139-53. doi: 10.1016/j.cellsig.2007.10.003. Epub 2007 Oct 12.
We report here the cloning and characterization of short and supershort mouse PDE4D isoforms. PDE4D is one of the phosphodiesterase enzyme families with multiple promoters and splice variants. PDE4 isoforms present in humans, rats and mice share considerable homology in their catalytic and regulatory domains. In this study, we have identified the novel PDE4D2 variant3 (PDE4D2v3) and PDE4D10 isoforms and the mouse orthologs of PDE4D1, PDE4D2 variant1 (PDE4D2v1), PDE4D2 variant2 (PDE4D2v2) and PDE4D6 isoforms. These isoforms have many different lengths of 5'UTR, signifying the use of different transcription start sites. Our data indicate that many novel PDE4D isoforms exist as a result of alternative mRNA splicing, each isoform having unique N-terminal regions and multiple transcription start sites. Subcellular distribution study showed that the PDE4D1 short isoforms are localized to the nucleus while the supershort isoforms (PDE4D2v1, PDE4D2v2, PDE4D2v3, PDE4D6 and PDE4D10) are restricted to the cytoplasm. Deletion study confirmed that the N-terminus of PDE4D1 is necessary for nuclear targeting. In addition, we showed that the unique N-terminus contains nuclear localization signal sequence. Identifying novel tissue-specific PDE4D isoforms with unique N-terminal regions may aid in the development of selective phosphodiesterase inhibitors.
我们在此报告短和超短小鼠PDE4D亚型的克隆与特性。PDE4D是具有多个启动子和剪接变体的磷酸二酯酶家族之一。人类、大鼠和小鼠中存在的PDE4亚型在其催化和调节结构域具有相当高的同源性。在本研究中,我们鉴定出了新型的PDE4D2变体3(PDE4D2v3)和PDE4D10亚型,以及PDE4D1、PDE4D2变体1(PDE4D2v1)、PDE4D2变体2(PDE4D2v2)和PDE4D6亚型的小鼠直系同源物。这些亚型具有许多不同长度的5'UTR,表明使用了不同的转录起始位点。我们的数据表明,由于选择性mRNA剪接,存在许多新型的PDE4D亚型,每个亚型都有独特的N端区域和多个转录起始位点。亚细胞分布研究表明,PDE4D1短亚型定位于细胞核,而超短亚型(PDE4D2v1、PDE4D2v2、PDE4D2v3、PDE4D6和PDE4D10)局限于细胞质。缺失研究证实,PDE4D1的N端对于核靶向是必需的。此外,我们表明独特的N端包含核定位信号序列。鉴定具有独特N端区域的新型组织特异性PDE4D亚型可能有助于开发选择性磷酸二酯酶抑制剂。